Matthew S. Kelly

High Impact

Section Chief, Infectious Diseases

Last publication 2025 Last refreshed 2026-05-16

faculty

COM | Peds Infectious Diseases

mkelly3@uams.edu

26 h-index 131 pubs 2,030 cited

Biography and Research Information

OverviewAI-generated summary

Matthew S. Kelly leads a research group focused on infectious diseases, with a particular emphasis on viral infections and the human microbiome in pediatric populations. His work has investigated host responses to SARS-CoV-2, including durable neutralizing antibody responses in children and adolescents following asymptomatic or mild infections. Kelly's research also explores the relationship between age-related changes in the nasopharyngeal microbiome and susceptibility to SARS-CoV-2. He has published on the role of non-diphtheriae Corynebacterium species in decreasing the risk of pneumococcal colonization during infancy and has evaluated the potential of Dolosigranulum pigrum as a nasal probiotic candidate.

Further research interests include the evaluation of novel vaccine candidates, such as recombinant live-attenuated respiratory syncytial virus (RSV) vaccines in children. Kelly has also examined risk factors for cytomegalovirus (CMV) viremia and associated adverse events in pediatric hematopoietic stem cell transplant recipients. His scholarship metrics include an h-index of 25, with 131 total publications and 1,986 total citations, marking him as a highly cited researcher.

Metrics

  • h-index: 26
  • Publications: 131
  • Citations: 2,030

Selected Publications

  • Health Utilities Associated with Pneumococcal Diseases in Children and Adults: A Targeted Literature Review and Meta-analysis (2026)
  • Early life factors documented in electronic health records predict recurrent acute otitis media (2026)
  • Indirect Effects in Health Economic Models of Vaccines: Should We Include Them, and How Do We Model Them? (2026)
  • P-484. Global Economic Burden Of Pneumococcal Disease In Children — Lessons Learned From Economic Evaluations Of Pneumococcal Vaccines (2026)
  • Indirect comparison of the immunogenicity of 15-valent and 20-valent pneumococcal conjugate vaccines in children using a 2+1 schedule (2025)
    1 citation DOI OpenAlex
  • Alterations of the upper respiratory microbiome among children living with HIV infection in Botswana (2022)
    2 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

314 Collaborators 140 Institutions 22 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics